$PLL
Piedmont Lithium Inc.

2024 Q4 Form 10-Q Financial Statement

#000172820524000096 Filed on November 12, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $27.66M
YoY Change -41.3%
Cost Of Revenue $25.01M
YoY Change 7.05%
Gross Profit $2.653M
YoY Change -88.84%
Gross Profit Margin 9.59%
Selling, General & Admin $9.466M
YoY Change -15.37%
% of Gross Profit 356.8%
Research & Development $35.00K
YoY Change -91.46%
% of Gross Profit 1.32%
Depreciation & Amortization $65.00K
YoY Change 8.33%
% of Gross Profit 2.45%
Operating Expenses $9.501M
YoY Change -18.49%
Operating Profit -$14.93M
YoY Change -193.52%
Interest Expense -$2.877M
YoY Change -36062.5%
% of Operating Profit
Other Income/Expense, Net -$1.762M
YoY Change -119.67%
Pretax Income -$16.70M
YoY Change -167.07%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$16.69M
YoY Change -172.9%
Net Earnings / Revenue -60.32%
Basic Earnings Per Share -$0.86
Diluted Earnings Per Share -$0.86
COMMON SHARES
Basic Shares Outstanding 19.44M shares 19.37M shares
Diluted Shares Outstanding 19.40M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $70.23M
YoY Change -26.07%
Cash & Equivalents $64.40M
Short-Term Investments $5.873M
Other Short-Term Assets $8.217M
YoY Change 87.86%
Inventory
Prepaid Expenses
Receivables $1.100M
Other Receivables $0.00
Total Short-Term Assets $73.65M
YoY Change -39.7%
LONG-TERM ASSETS
Property, Plant & Equipment $134.5M
YoY Change 15.54%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $80.15M
YoY Change -39.76%
Other Assets $1.707M
YoY Change -93.37%
Total Long-Term Assets $255.6M
YoY Change -7.13%
TOTAL ASSETS
Total Short-Term Assets $73.65M
Total Long-Term Assets $255.6M
Total Assets $329.2M
YoY Change -17.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.819M
YoY Change -80.29%
Accrued Expenses $224.0K
YoY Change
Deferred Revenue $6.866M
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $19.97M
YoY Change 9833.33%
Total Short-Term Liabilities $37.03M
YoY Change -13.61%
LONG-TERM LIABILITIES
Long-Term Debt $4.089M
YoY Change 9193.18%
Other Long-Term Liabilities $998.0K
YoY Change -16.83%
Total Long-Term Liabilities $5.087M
YoY Change 11461.36%
TOTAL LIABILITIES
Total Short-Term Liabilities $37.03M
Total Long-Term Liabilities $5.087M
Total Liabilities $43.02M
YoY Change -12.73%
SHAREHOLDERS EQUITY
Retained Earnings -$180.5M
YoY Change 76.96%
Common Stock $2.000K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $286.2M
YoY Change
Total Liabilities & Shareholders Equity $329.2M
YoY Change -17.14%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$16.69M
YoY Change -172.9%
Depreciation, Depletion And Amortization $65.00K
YoY Change 8.33%
Cash From Operating Activities -$7.696M
YoY Change -130.67%
INVESTING ACTIVITIES
Capital Expenditures $1.956M
YoY Change -87.99%
Acquisitions
YoY Change
Other Investing Activities -$2.100M
YoY Change -17.32%
Cash From Investing Activities -$4.056M
YoY Change -78.44%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 17.13M
YoY Change -3332.45%
NET CHANGE
Cash From Operating Activities -7.696M
Cash From Investing Activities -4.056M
Cash From Financing Activities 17.13M
Net Change In Cash 5.380M
YoY Change -6.43%
FREE CASH FLOW
Cash From Operating Activities -$7.696M
Capital Expenditures $1.956M
Free Cash Flow -$9.652M
YoY Change -209.56%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001728205
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Security12b Title
Security12bTitle
Common stock, $0.0001 par value per share
dei Trading Symbol
TradingSymbol
PLL
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
19437632 shares
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
36-4996461
dei Entity Address Address Line1
EntityAddressAddressLine1
42 E Catawba Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Belmont
dei Entity Address State Or Province
EntityAddressStateOrProvince
NC
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
311067000 usd
CY2024Q2 us-gaap Oci Equity Method Investment After Tax Parent
OciEquityMethodInvestmentAfterTaxParent
-758000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-13332000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
299625000 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2358000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
149000 usd
us-gaap Net Income Loss
NetIncomeLoss
3613000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
6869000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
7378000 usd
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19401000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19239000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.19
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.86
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.77
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1206000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
169000 shares
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
54291000 usd
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
25010000 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
23363000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
50321000 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
2653000 usd
us-gaap Gross Profit
GrossProfit
3970000 usd
us-gaap Gross Profit
GrossProfit
23764000 usd
CY2024Q3 us-gaap Exploration Expense
ExplorationExpense
35000 usd
us-gaap Exploration Expense
ExplorationExpense
97000 usd
us-gaap Exploration Expense
ExplorationExpense
1668000 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
11185000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
26576000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
31793000 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
9501000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
11656000 usd
us-gaap Operating Expenses
OperatingExpenses
33461000 usd
CY2024Q3 pll Income Loss From Equity Method Investments Including Impairment
IncomeLossFromEquityMethodInvestmentsIncludingImpairment
-3514000 usd
CY2023Q3 pll Income Loss From Equity Method Investments Including Impairment
IncomeLossFromEquityMethodInvestmentsIncludingImpairment
3852000 usd
pll Income Loss From Equity Method Investments Including Impairment
IncomeLossFromEquityMethodInvestmentsIncludingImpairment
-13864000 usd
pll Income Loss From Equity Method Investments Including Impairment
IncomeLossFromEquityMethodInvestmentsIncludingImpairment
-1565000 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.77
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19366000 shares
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
Piedmont Lithium Inc.
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
28012
dei City Area Code
CityAreaCode
704
dei Local Phone Number
LocalPhoneNumber
461-8000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
47127000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
47127000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
23363000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
23764000 usd
CY2023Q3 us-gaap Exploration Expense
ExplorationExpense
471000 usd
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
9466000 usd
us-gaap Operating Expenses
OperatingExpenses
26673000 usd
CY2024Q3 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
4563000 usd
CY2023Q3 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
0 usd
us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
6657000 usd
us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
0 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-14925000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
15960000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-43224000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-11262000 usd
CY2024Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
806000 usd
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
1031000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
2286000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
2959000 usd
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
169000 usd
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
8000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
467000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
34000 usd
CY2024Q3 pll Gain Loss On Sale And Dilution Of Equity Method Investments
GainLossOnSaleAndDilutionOfEquityMethodInvestments
0 usd
CY2023Q3 pll Gain Loss On Sale And Dilution Of Equity Method Investments
GainLossOnSaleAndDilutionOfEquityMethodInvestments
7958000 usd
pll Gain Loss On Sale And Dilution Of Equity Method Investments
GainLossOnSaleAndDilutionOfEquityMethodInvestments
-13886000 usd
pll Gain Loss On Sale And Dilution Of Equity Method Investments
GainLossOnSaleAndDilutionOfEquityMethodInvestments
15208000 usd
CY2024Q3 us-gaap Other Nonoperating Gains Losses
OtherNonoperatingGainsLosses
-2399000 usd
CY2023Q3 us-gaap Other Nonoperating Gains Losses
OtherNonoperatingGainsLosses
-22000 usd
us-gaap Other Nonoperating Gains Losses
OtherNonoperatingGainsLosses
-1434000 usd
us-gaap Other Nonoperating Gains Losses
OtherNonoperatingGainsLosses
-88000 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1762000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
8959000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-13501000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
18045000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-16687000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
24919000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-56725000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6783000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2028000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3095000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3170000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-16687000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
22891000 usd
us-gaap Net Income Loss
NetIncomeLoss
-53630000 usd
us-gaap Net Income Loss
NetIncomeLoss
3613000 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.86
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.19
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.19
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.86
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.19
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.77
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.19
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19401000 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19203000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18974000 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19401000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19239000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19366000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19011000 shares
CY2023Q3 pll Gain Loss On Dilution Of Equity Method Investments
GainLossOnDilutionOfEquityMethodInvestments
7958000 usd
pll Gain Loss On Dilution Of Equity Method Investments
GainLossOnDilutionOfEquityMethodInvestments
15208000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-16687000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
22891000 usd
us-gaap Net Income Loss
NetIncomeLoss
-53630000 usd
us-gaap Net Income Loss
NetIncomeLoss
3613000 usd
CY2024Q3 pll Oci Foreign Currency Translation Adjustment Of Equity Method Investments Net Of Tax Parent
OCIForeignCurrencyTranslationAdjustmentOfEquityMethodInvestmentsNetOfTaxParent
927000 usd
CY2023Q3 pll Oci Foreign Currency Translation Adjustment Of Equity Method Investments Net Of Tax Parent
OCIForeignCurrencyTranslationAdjustmentOfEquityMethodInvestmentsNetOfTaxParent
-2992000 usd
pll Oci Foreign Currency Translation Adjustment Of Equity Method Investments Net Of Tax Parent
OCIForeignCurrencyTranslationAdjustmentOfEquityMethodInvestmentsNetOfTaxParent
256000 usd
pll Oci Foreign Currency Translation Adjustment Of Equity Method Investments Net Of Tax Parent
OCIForeignCurrencyTranslationAdjustmentOfEquityMethodInvestmentsNetOfTaxParent
-4084000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
927000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-2992000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
256000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4084000 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15760000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
19899000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-53374000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-471000 usd
pll Oci Foreign Currency Translation Adjustment Of Equity Method Investments Tax Parent
OCIForeignCurrencyTranslationAdjustmentOfEquityMethodInvestmentsTaxParent
223000 usd
CY2023Q3 pll Oci Foreign Currency Translation Adjustment Of Equity Method Investments Tax Parent
OCIForeignCurrencyTranslationAdjustmentOfEquityMethodInvestmentsTaxParent
-264000 usd
pll Oci Foreign Currency Translation Adjustment Of Equity Method Investments Tax Parent
OCIForeignCurrencyTranslationAdjustmentOfEquityMethodInvestmentsTaxParent
-830000 usd
CY2024Q3 pll Oci Foreign Currency Translation Adjustment Of Equity Method Investments Tax Parent
OCIForeignCurrencyTranslationAdjustmentOfEquityMethodInvestmentsTaxParent
0 usd
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
64358000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
71730000 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1079000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
595000 usd
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
8217000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
3829000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
73654000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
76154000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
134510000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
127086000 usd
CY2024Q3 us-gaap Advances To Affiliate
AdvancesToAffiliate
39208000 usd
CY2023Q4 us-gaap Advances To Affiliate
AdvancesToAffiliate
28189000 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1707000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2164000 usd
CY2024Q3 us-gaap Equity Method Investments
EquityMethodInvestments
80148000 usd
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
147662000 usd
CY2024Q3 us-gaap Assets
Assets
329227000 usd
CY2023Q4 us-gaap Assets
Assets
381255000 usd
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
6532000 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
11580000 usd
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
19966000 usd
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
6866000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
0 usd
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3375000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
29463000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
37026000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
41366000 usd
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4089000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
14000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
908000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1091000 usd
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
998000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
431000 usd
CY2024Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
0 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
6023000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
43021000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
48925000 usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19429000 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19429000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19272000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19272000 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
2000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
2000 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
470149000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
462899000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-180474000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-126844000 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3471000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3727000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
286206000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
332330000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
329227000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
381255000 usd
us-gaap Net Income Loss
NetIncomeLoss
-53630000 usd
pll Income Loss From Equity Method Investments Including Impairment
IncomeLossFromEquityMethodInvestmentsIncludingImpairment
-13864000 usd
pll Income Loss From Equity Method Investments Including Impairment
IncomeLossFromEquityMethodInvestmentsIncludingImpairment
-1565000 usd
pll Gain Loss On Sale And Dilution Of Equity Method Investments
GainLossOnSaleAndDilutionOfEquityMethodInvestments
-13886000 usd
pll Gain Loss On Sale And Dilution Of Equity Method Investments
GainLossOnSaleAndDilutionOfEquityMethodInvestments
15208000 usd
us-gaap Equity Securities Fv Ni Realized Loss
EquitySecuritiesFvNiRealizedLoss
1036000 usd
us-gaap Equity Securities Fv Ni Realized Loss
EquitySecuritiesFvNiRealizedLoss
0 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-6246000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
3170000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
221000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
174000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
280000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
169000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-691000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
4070000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
us-gaap Foreign Currency Transaction Gain Loss Unrealized After Tax
ForeignCurrencyTransactionGainLossUnrealizedAfterTax
309000 usd
us-gaap Foreign Currency Transaction Gain Loss Unrealized After Tax
ForeignCurrencyTransactionGainLossUnrealizedAfterTax
-27000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
484000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
23281000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-2675000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1633000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-208000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-148000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-25372000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
7751000 usd
us-gaap Increase Decrease In Due To Affiliates Current
IncreaseDecreaseInDueToAffiliatesCurrent
113000 usd
us-gaap Increase Decrease In Due To Affiliates Current
IncreaseDecreaseInDueToAffiliatesCurrent
21484000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
6866000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
0 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-799000 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
342000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-36477000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5403000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10578000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
44978000 usd
us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
10310000 usd
us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
6828000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
45000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
0 usd
us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
49103000 usd
us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
0 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
14982000 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
28667000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
13278000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-80473000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
71084000 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
18007000 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 usd
pll Payments Of Debt And Insurance Premiums F Inanced
PaymentsOfDebtAndInsurancePremiumsFInanced
1509000 usd
pll Payments Of Debt And Insurance Premiums F Inanced
PaymentsOfDebtAndInsurancePremiumsFInanced
344000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
671000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
422000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
15827000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
70318000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-7372000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4752000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
71730000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
99247000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
64358000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
94495000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
37000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
5114000 usd
us-gaap Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1
NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1
5277000 usd
us-gaap Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1
NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1
0 usd
pll Notes Payable For Insurance Contract
NotesPayableForInsuranceContract
2117000 usd
pll Notes Payable For Insurance Contract
NotesPayableForInsuranceContract
0 usd
pll Noncash Investment In Affiliates For Issuance Of Company Stock
NoncashInvestmentInAffiliatesForIssuanceOfCompanyStock
746000 usd
pll Noncash Investment In Affiliates For Issuance Of Company Stock
NoncashInvestmentInAffiliatesForIssuanceOfCompanyStock
0 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
332330000 usd
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
747000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2106000 usd
CY2024Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
592000 usd
CY2024Q1 us-gaap Oci Equity Method Investment After Tax Parent
OciEquityMethodInvestmentAfterTaxParent
87000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-23611000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2710000 usd
CY2024Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
62000 usd
CY2024Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
17000 usd
CY2024Q3 us-gaap Oci Equity Method Investment After Tax Parent
OciEquityMethodInvestmentAfterTaxParent
927000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-16687000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
286206000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
270289000 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
71084000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1166000 usd
CY2023Q1 us-gaap Oci Equity Method Investment After Tax Parent
OciEquityMethodInvestmentAfterTaxParent
-2213000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-8639000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
331687000 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3266000 usd
CY2023Q2 us-gaap Oci Equity Method Investment After Tax Parent
OciEquityMethodInvestmentAfterTaxParent
1121000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-10639000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
325435000 usd
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3139000 usd
CY2023Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
422000 usd
CY2023Q3 us-gaap Oci Equity Method Investment After Tax Parent
OciEquityMethodInvestmentAfterTaxParent
-2992000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
22891000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
348051000 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, assumptions, and allocations that affect amounts reported in the consolidated financial statements and related notes. Significant items that are subject to such estimates and assumptions include, but are not limited to, long-lived assets, fair value of stock-based compensation awards and marketable securities, income tax uncertainties, valuation of deferred tax assets, contingent assets and liabilities, legal claims, asset impairments, provisional revenue adjustments, collectability of receivables, and environmental remediation. Actual results could differ due to the uncertainty inherent in the nature of these estimates.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We base our estimates and assumptions on current facts, historical experience, and various other factors that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. Actual results may differ materially and adversely from our estimates. To the extent there are material differences between estimates and actual results, future results of operations will be affected.</span></div>
us-gaap Net Income Loss
NetIncomeLoss
-53600000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-21800000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-180500000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-126800000 usd
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
64400000 usd
pll Number Of Customers
NumberOfCustomers
4 customer
pll Number Of Customers
NumberOfCustomers
4 customer
CY2024Q3 pll Number Of Customers
NumberOfCustomers
4 customer
CY2023Q3 pll Number Of Customers
NumberOfCustomers
4 customer
CY2024Q3 pll Long Term Supply Agreement Spodumene Concentrate Production
LongTermSupplyAgreementSpodumeneConcentrateProduction
1800 t
CY2024Q3 pll Long Term Supply Agreement Ceiling Price
LongTermSupplyAgreementCeilingPrice
610
CY2024Q3 pll Revenue Gross
RevenueGross
27663000 usd
CY2023Q3 pll Revenue Gross
RevenueGross
47127000 usd
pll Revenue Gross
RevenueGross
54053000 usd
pll Revenue Gross
RevenueGross
47127000 usd
CY2024Q3 pll Provisional Revenue Adjustments
ProvisionalRevenueAdjustments
0 usd
CY2023Q3 pll Provisional Revenue Adjustments
ProvisionalRevenueAdjustments
0 usd
pll Provisional Revenue Adjustments
ProvisionalRevenueAdjustments
-238000 usd
pll Provisional Revenue Adjustments
ProvisionalRevenueAdjustments
0 usd
CY2024Q3 us-gaap Revenues
Revenues
27663000 usd
CY2023Q3 us-gaap Revenues
Revenues
47127000 usd
us-gaap Revenues
Revenues
54291000 usd
us-gaap Revenues
Revenues
47127000 usd
CY2024Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
6900000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
0 usd
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
10100000 usd
CY2024Q3 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
2417000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
3139000 usd
us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
7283000 usd
us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
7576000 usd
CY2024Q3 us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
59000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
0 usd
us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
109000 usd
us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
5000 usd
CY2024Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2358000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3139000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
7174000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
7571000 usd
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2229000 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3067000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6869000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7378000 usd
CY2024Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
129000 usd
CY2023Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
72000 usd
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
305000 usd
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
193000 usd
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
2358000 usd
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
3139000 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
7174000 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
7571000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.40
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
295000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
265000 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
155000 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
42000 shares
CY2024Q1 pll Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Surrendered Or Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedSurrenderedOrVestedInPeriod
0 shares
CY2023Q1 pll Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Surrendered Or Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedSurrenderedOrVestedInPeriod
0 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
0 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
0 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
450000 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
307000 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
170000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
30000 shares
CY2024Q2 pll Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Surrendered Or Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedSurrenderedOrVestedInPeriod
0 shares
CY2023Q2 pll Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Surrendered Or Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedSurrenderedOrVestedInPeriod
0 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
0 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
0 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
620000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
337000 shares
CY2024Q3 pll Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Surrendered Or Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedSurrenderedOrVestedInPeriod
0 shares
CY2023Q3 pll Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Surrendered Or Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedSurrenderedOrVestedInPeriod
2000 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
0 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
0 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
620000 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
335000 shares
CY2024Q3 us-gaap Restructuring Charges
RestructuringCharges
493000 usd
us-gaap Restructuring Charges
RestructuringCharges
2587000 usd
CY2024Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
4070000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
4070000 usd
CY2024Q3 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
4563000 usd
us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
6657000 usd
CY2023Q4 us-gaap Restructuring Reserve
RestructuringReserve
0 usd
CY2024Q1 us-gaap Restructuring Charges
RestructuringCharges
1780000 usd
CY2024Q1 us-gaap Payments For Restructuring
PaymentsForRestructuring
757000 usd
CY2024Q1 us-gaap Restructuring Reserve Settled Without Cash2
RestructuringReserveSettledWithoutCash2
554000 usd
CY2024Q1 us-gaap Restructuring Reserve
RestructuringReserve
469000 usd
CY2024Q2 us-gaap Restructuring Charges
RestructuringCharges
314000 usd
CY2024Q2 us-gaap Payments For Restructuring
PaymentsForRestructuring
701000 usd
CY2024Q2 us-gaap Restructuring Reserve
RestructuringReserve
82000 usd
CY2024Q3 us-gaap Restructuring Charges
RestructuringCharges
493000 usd
CY2024Q3 us-gaap Payments For Restructuring
PaymentsForRestructuring
232000 usd
CY2024Q3 us-gaap Restructuring Reserve
RestructuringReserve
343000 usd
CY2024Q3 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
-2630000 usd
CY2023Q3 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
0 usd
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
-1036000 usd
us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
0 usd
CY2024Q3 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-35000 usd
CY2023Q3 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-691000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 usd
CY2024Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
266000 usd
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-22000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
293000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-88000 usd
CY2024Q3 us-gaap Other Nonoperating Gains Losses
OtherNonoperatingGainsLosses
-2399000 usd
CY2023Q3 us-gaap Other Nonoperating Gains Losses
OtherNonoperatingGainsLosses
-22000 usd
us-gaap Other Nonoperating Gains Losses
OtherNonoperatingGainsLosses
-1434000 usd
us-gaap Other Nonoperating Gains Losses
OtherNonoperatingGainsLosses
-88000 usd
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-16687000 usd
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-16687000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
22891000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
22891000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-53630000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-53630000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-53630000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-53630000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
3613000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3613000 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19401000 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19203000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19366000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18974000 shares
CY2024Q3 us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
0 shares
CY2023Q3 us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
36000 shares
us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
0 shares
us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
37000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19366000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19011000 shares
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.86
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.19
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.77
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.19
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.19
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1206000 shares
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
391000 shares
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-16700000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000000.0 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
24900000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3100000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-56700000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3200000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6800000 usd
CY2024Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.081
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.055
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.467
CY2024Q2 us-gaap Equity Method Investments
EquityMethodInvestments
82719000 usd
CY2024Q3 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
16000 usd
CY2024Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-3514000 usd
CY2024Q3 pll Oci Foreign Currency Translation Adjustment Of Equity Method Investments Before Tax Parent
OCIForeignCurrencyTranslationAdjustmentOfEquityMethodInvestmentsBeforeTaxParent
927000 usd
CY2024Q3 us-gaap Equity Method Investments
EquityMethodInvestments
80148000 usd
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
147662000 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
14982000 usd
pll Gain Loss On Dilution Of Equity Method Investments
GainLossOnDilutionOfEquityMethodInvestments
186000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-13864000 usd
pll Oci Foreign Currency Translation Adjustment Of Equity Method Investments Before Tax Parent
OCIForeignCurrencyTranslationAdjustmentOfEquityMethodInvestmentsBeforeTaxParent
479000 usd
us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
49103000 usd
us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
-14072000 usd
pll Equity Method Investments Transfer To Investments In Marketable Securities
EquityMethodInvestmentsTransferToInvestmentsInMarketableSecurities
-6122000 usd
CY2024Q3 us-gaap Equity Method Investments
EquityMethodInvestments
80148000 usd
CY2023Q2 us-gaap Equity Method Investments
EquityMethodInvestments
124040000 usd
CY2023Q3 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
450000 usd
CY2023Q3 pll Gain Loss On Dilution Of Equity Method Investments
GainLossOnDilutionOfEquityMethodInvestments
7958000 usd
CY2023Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
3852000 usd
CY2023Q3 pll Oci Foreign Currency Translation Adjustment Of Equity Method Investments Before Tax Parent
OCIForeignCurrencyTranslationAdjustmentOfEquityMethodInvestmentsBeforeTaxParent
-3256000 usd
CY2023Q3 us-gaap Equity Method Investments
EquityMethodInvestments
133044000 usd
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
95648000 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
28667000 usd
pll Gain Loss On Dilution Of Equity Method Investments
GainLossOnDilutionOfEquityMethodInvestments
15208000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1565000 usd
pll Oci Foreign Currency Translation Adjustment Of Equity Method Investments Before Tax Parent
OCIForeignCurrencyTranslationAdjustmentOfEquityMethodInvestmentsBeforeTaxParent
-4914000 usd
CY2023Q3 us-gaap Equity Method Investments
EquityMethodInvestments
133044000 usd
us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
54300000 usd
CY2024Q3 us-gaap Advances To Affiliate
AdvancesToAffiliate
39208000 usd
CY2023Q4 us-gaap Advances To Affiliate
AdvancesToAffiliate
28189000 usd
CY2024Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
5627000 usd
CY2023Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
0 usd
CY2024Q3 pll Prepaid Expense Current And Other Current Assets Miscellaneous
PrepaidExpenseCurrentAndOtherCurrentAssetsMiscellaneous
2344000 usd
CY2023Q4 pll Prepaid Expense Current And Other Current Assets Miscellaneous
PrepaidExpenseCurrentAndOtherCurrentAssetsMiscellaneous
3345000 usd
CY2024Q3 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
246000 usd
CY2023Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
484000 usd
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
8217000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
3829000 usd
CY2024Q3 us-gaap Marketable Securities Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments
-2600000 usd
us-gaap Marketable Securities Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments
-800000 usd
us-gaap Equity Securities Fv Ni Unrealized Loss
EquitySecuritiesFvNiUnrealizedLoss
200000 usd
us-gaap Debt And Equity Securities Unrealized Gain Loss
DebtAndEquitySecuritiesUnrealizedGainLoss
0 usd
CY2024Q3 us-gaap Debt And Equity Securities Unrealized Gain Loss
DebtAndEquitySecuritiesUnrealizedGainLoss
0 usd
CY2023Q3 us-gaap Debt And Equity Securities Unrealized Gain Loss
DebtAndEquitySecuritiesUnrealizedGainLoss
0 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1030000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1371000 usd
CY2024Q3 pll Asset Retirement Obligation Net Of Accumulated Depreciation
AssetRetirementObligationNetOfAccumulatedDepreciation
393000 usd
CY2023Q4 pll Asset Retirement Obligation Net Of Accumulated Depreciation
AssetRetirementObligationNetOfAccumulatedDepreciation
414000 usd
CY2024Q3 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
284000 usd
CY2023Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
379000 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1707000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2164000 usd
CY2024Q3 pll Asset Retirement Obligation Accumulated Amortization
AssetRetirementObligationAccumulatedAmortization
28000 usd
CY2023Q4 pll Asset Retirement Obligation Accumulated Amortization
AssetRetirementObligationAccumulatedAmortization
7000 usd
CY2024Q3 pll Tax Payable On Gain Of Equity Method Investment Disposal
TaxPayableOnGainOfEquityMethodInvestmentDisposal
3151000 usd
CY2023Q4 pll Tax Payable On Gain Of Equity Method Investment Disposal
TaxPayableOnGainOfEquityMethodInvestmentDisposal
0 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
163000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
312000 usd
CY2024Q3 us-gaap Interest Payable Current
InterestPayableCurrent
61000 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
0 usd
CY2024Q3 pll Accrued Provisional Revenue Adjustment
AccruedProvisionalRevenueAdjustment
0 usd
CY2023Q4 pll Accrued Provisional Revenue Adjustment
AccruedProvisionalRevenueAdjustment
29151000 usd
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3375000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
29463000 usd
CY2024Q3 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
24055000 usd
CY2023Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
163000 usd
CY2024Q3 us-gaap Debt Current
DebtCurrent
19966000 usd
CY2023Q4 us-gaap Debt Current
DebtCurrent
149000 usd
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4089000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
14000 usd
CY2024Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
169000 usd
CY2023Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
8000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
467000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
34000 usd
CY2024Q3 us-gaap Interest Paid Net
InterestPaidNet
119000 usd
CY2023Q3 us-gaap Interest Paid Net
InterestPaidNet
8000 usd
us-gaap Interest Paid Net
InterestPaidNet
406000 usd
us-gaap Interest Paid Net
InterestPaidNet
34000 usd
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q2 srt Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
50000000 usd
CY2024Q1 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
52701 shares
CY2024Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
14.17
CY2024Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1100000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
600000 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1100000 usd
CY2024Q3 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
24100000 usd
CY2023Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
200000 usd
CY2024Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
5600000 usd
CY2023Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
0 usd
CY2024Q3 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
200000 usd
CY2023Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
500000 usd
CY2024Q1 pll Loss Contingency Number Of Actions Consolidated
LossContingencyNumberOfActionsConsolidated
2 action
CY2024Q2 pll Number Of Petitioners
NumberOfPetitioners
4 petitioner
CY2023Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
400000 usd
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
pll-20240930_lab.xml Edgar Link unprocessable
0001728205-24-000096-index-headers.html Edgar Link pending
0001728205-24-000096-index.html Edgar Link pending
0001728205-24-000096.txt Edgar Link pending
0001728205-24-000096-xbrl.zip Edgar Link pending
ex311-10q_2024q3.htm Edgar Link pending
ex312-10q_2024q3.htm Edgar Link pending
ex321-10q_2023q3.htm Edgar Link pending
ex322-10q_2024q3.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pll-20240930.htm Edgar Link pending
pll-20240930.xsd Edgar Link pending
pll-20240930_g1.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
pll-20240930_cal.xml Edgar Link unprocessable
pll-20240930_def.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
pll-20240930_pre.xml Edgar Link unprocessable
pll-20240930_htm.xml Edgar Link completed
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending